Clinical

Dataset Information

0

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients


ABSTRACT: Oxaliplatin(OXA) chemotherapy protocols are used in treatment of cancers like colorectal (CRC) and pancreatic cancer. OXA causes peripheral neuropathy which is considered treatment limiting factor. In recent studies, it shows that omeprazole(OME) has antioxidant effect and can inhibit organic cation transporter 2 (OCT2) in kidney. So OME can protect against peripheral neuropathy induced by OXA through oxidative stress . Also OME activates extracellular-signal-regulated kinase(ERK) / mitogen activated protein kinase ( MAPK) pathway, so improves demyelinating symptoms.

DISEASE(S): Chemotherapy Induced Peripheral Neuropathy,Peripheral Nervous System Diseases,Colorectal Cancer,Pancreatic Cancer

PROVIDER: 4711 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-07-12 | GSE179918 | GEO
| 2221663 | ecrin-mdr-crc
2021-01-23 | GSE165304 | GEO
2021-01-23 | GSE165302 | GEO
2013-03-13 | E-GEOD-44605 | biostudies-arrayexpress
| 2109499 | ecrin-mdr-crc
2010-07-06 | E-GEOD-18614 | biostudies-arrayexpress
| PRJNA273670 | ENA
2022-12-02 | GSE218664 | GEO
2013-03-13 | GSE44605 | GEO